Industry News
Stay up to date with the latest news in the industry
LATEST NEWS
Sanofi-aventis has announced that its investigational once-daily oral drug teriflunomide for the treatment of relapsing multiple sclerosis (RMS), has met the primary endpoint in its Phase III trial.
02 September 2010
Trius Initiates Clinical Study of Skin Infection Drug
02 September 2010
02 September 2010
BioMarin Receives Orphan Drug Designation for Pompe Disease Drug
01 September 2010
01 September 2010
Portola Announces Positive Results for Anti-Platelet Drug
01 September 2010
01 September 2010
Plexxikon Announces Positive Results of Melanoma Drug Study
31 August 2010
31 August 2010
Pharmasset Initiates Hepatitis C Drug Trial
31 August 2010
31 August 2010
GlaxoSmithKline Begins Phase III Trials of Shingles Vaccine
27 August 2010
27 August 2010
Eisai Announces Positive Study Results for Epilepsy Drug
27 August 2010
27 August 2010
Pfizer Announces Mixed Lung Cancer Drug Results
26 August 2010
26 August 2010
FDA Grants Tentative Approval for Generic HIV Drug
26 August 2010
26 August 2010
FDA to Priority Review Bristol-Myers Squibb Melanoma Drug
23 August 2010
23 August 2010
